Progress in Pediatric Cardiology

Aims & Scope

Progress in Pediatric Cardiology provides a rich mix of news, opinion, debate and research for academics, clinicians, healthcare managers and policy makers on all aspects of the understanding, management and improvement of cardiovascular diseases in children.

PPC is led by a patient-focused editorial team embracing an interdisciplinary approach to disseminate evidence and advance knowledge to improve pediatric cardiovascular care.

PPC is committed to publishing high-quality papers in all areas of pediatric cardiovascular care through a fair and rigorous peer review process.

The journal offers continuous online publication and is published quarterly in print.

View Aims & Scope

---

Metrics & Ranking

SJR (SCImago Journal Rank)

Year	Value
2024	0.230

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	37

Impact Factor

Year	Value
2024	0.60

Journal Rank

Year	Value
2024	19550

Journal Citation Indicator

Year	Value
2024	120

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The Pediatric Quality of Life Inventoryâ„¢ in children with heart disease

  Citation: 165

  Authors: Karen, Karen, Tasha M., James W.

• Bioenergetics, mitochondria, and cardiac myocyte differentiation

  Citation: 132

  Authors: George A., Jennifer R., David L., Rodrigo A., Karen L. de Mesy, Shey-Shing

• COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; a Western New York approach

  Citation: 127

  Authors: Teresa R., Michelle D., Rabheh, Omar S., Megan B., Andrew J., Beverly A., Steven J., John V., Stephen J., Oscar G., Mark D.

• Disruption of healthcare: Will the COVID pandemic worsen non-COVID outcomes and disease outbreaks?

  Citation: 124

  Authors: Paul, Stacy D., M. Jacob, Gale R., Patrick D., Dennis Z., Steven E.

• The costamere bridges sarcomeres to the sarcolemma in striated muscle

  Citation: 119

  Authors: Angela K., Hongqiang, Robert S., Kirk U., Ju

• Effects of congenital heart disease on brain development

  Citation: 119

  Authors: Patrick S., Donna A., Daniel J.

• Cardiomyopathies in Noonan syndrome and the other RASopathies

  Citation: 109

  Authors: Bruce D., Amy E., Marco

• Decreasing the burden of congenital heart anomalies: an epidemiologic evaluation of risk factors and survival

  Citation: 108

  Authors: Lorenzo D, Adolfo

• Neuropsychological, psychosocial, and quality-of-life outcomes in children and adolescents with congenital heart disease

  Citation: 94

  Authors: David C., Jane W.

• Genetic causes of dilated cardiomyopathy

  Citation: 88

  Authors: Luisa, Francesca, Anita, Gianfranco, Matthew R.G.

---